Russia’s foreign partners beginning to better see roots of Ukrainian crisis — envoy
Russia fighting against IS complying with UN SC resolutions — Spanish foreign ministry
Russia’s only infantry fighting vehicle manufacturer files for bankruptcy
Merkel intentionally criticized Russia on visit to Turkey — lawmaker
Russian snap check to involve 8,500 troops, 900 hardware units, 50 ships, 200 aircraft
Russia’s government delegation heading for talks to IraqRussian Politics & Diplomacy February 10, 9:18
Russia’s only infantry fighting vehicle manufacturer files for bankruptcyMilitary & Defense February 10, 8:51
Moscow concerned over Seoul’s plans of deployment of US missile defense systemsRussian Politics & Diplomacy February 10, 8:46
Russian diplomat confident North Stream-2 will be finally implementedBusiness & Economy February 10, 8:34
Russia submits revised application for extending Arctic shelf to UNRussian Politics & Diplomacy February 10, 4:36
PM Medvedev to discuss 2016 economic development action plan with GovernmentBusiness & Economy February 10, 1:40
Lavrov flies more than 3 mln kilometers since 2004 - mediaRussian Politics & Diplomacy February 10, 0:48
Russia expects UN to give positive reply to its Arctic bid - minister of natural resourcesRussian Politics & Diplomacy February 10, 0:17
Critical mass accumulated in EU for lifting of sanctions against Russia - envoy to EURussian Politics & Diplomacy February 10, 0:00
NOVOSIBIRSK, October 30 (Itar-Tass) - Scientists of the Institute of Clinical Immunology in the Siberian branch of the Russian Academy of Medical Sciences in Novosibirsk have developed a vaccine for the treatment of cancer, the institute's director, Professor Vladimir Kozlov, told Itar-Tass on Wednesday.
The vaccine has already successfully passed clinical tests. Currently, it is being given to patients by injection at the third and fourth stages of cancer and is reported as having increased patient lifespan more than twofold.
“We are deriving dendritic cells from the human body and loading them with tumor antigens," the scientist said. "Dendritic cells process them, then we inject the cells into the patient and they start working in the body evoking a strong immune response. That is, they are actively fighting the tumor."
The institute's creation "is not a classical vaccine, which is the means to prevent the illness", Professor Kozlov said. "In fact, it is cell therapy.”
The vaccine is counteracting several types of cancer - colorectal (bowel) cancer, breast cancer and prostate cancer - and the institute is ready to start its industrial production, Kozlov added.
He warned, however, that “one should not seek a panacea for malign tumors as they cannot be overcome with only one tool. Along with dendritic cells, there are other cells that fight cancer so all means are to be applied in complex. An immunomodulating cocktail is needed for a far-reaching effect,” Kozlov said.
Other types of therapy were to be used as well, such as chemotherapy and radiation therapy, the professor said. Treatment should vary case by case, he said, adding that the institute was already developing preventive vaccines against other illnesses, atherosclerosis among them, and that they would be presented soon.